Rifampin Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Rifampin Injection (injection) from Fresenius Kabi USA, LLC with status Current. The shortage was first posted on Feb 17, 2021. Reported reason: Other
Shortage details
- Status
- Current
- Company
- Fresenius Kabi USA, LLC
- Package NDC
- 63323-351-20
- Dosage Form
- Injection
- Presentation
- Rifampin, Injection, 600 mg (NDC 63323-351-20)
- Initial Posting
- Feb 17, 2021
Reason
Other